What is Maxigen Biotech Price-to-Operating-Cash-Flow?
As of today (2024-06-20), Maxigen Biotech's share price is NT$45.70.
Maxigen Biotech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$2.26. Hence, Maxigen Biotech's Price-to-Operating-Cash-Flow Ratio for today is 20.25.
The historical rank and industry rank for Maxigen Biotech's Price-to-Operating-Cash-Flow or its related term are showing as below:
TPE:1783'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.57 Med: 23.12 Max: 92.84
Current: 20.25
During the past 13 years, Maxigen Biotech's highest Price-to-Operating-Cash-Flow Ratio was 92.84. The lowest was 8.57. And the median was 23.12.
Maxigen Biotech's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was NT$0.61.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$2.26.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Maxigen Biotech was -14.20% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 27.40% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 10.60% per year.
During the past 13 years, Maxigen Biotech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 48.70% per year. The lowest was -9.90% per year. And the median was 20.25% per year.
Maxigen Biotech Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Maxigen Biotech's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maxigen Biotech Price-to-Operating-Cash-Flow Chart
|
Maxigen Biotech Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
20.34 |
21.43 |
32.28 |
15.12 |
25.29 |
|
Maxigen Biotech Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
20.15 |
21.64 |
26.30 |
25.29 |
20.20 |
Competitive Comparison of Maxigen Biotech's Price-to-Operating-Cash-Flow
For the Medical Instruments & Supplies subindustry, Maxigen Biotech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maxigen Biotech's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Maxigen Biotech's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Maxigen Biotech's Price-to-Operating-Cash-Flow falls into.
Maxigen Biotech Price-to-Operating-Cash-Flow Calculation
Maxigen Biotech's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 45.70 | / | 2.257 |
| = | 20.25 |
Maxigen Biotech's Share Price of today is NT$45.70.
Maxigen Biotech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$2.26.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Maxigen Biotech (TPE:1783) Business Description
Traded in Other Exchanges
N/A
Address
No. 88, Keji 1st Rd, Guishan District, Taoyuan City, TWN, 333
Maxigen Biotech Inc specializes in the developing, manufacturing, and marketing of biomedical and cosmeceutical skincare products. It provides medical devices for orthopedic, ophthalmic, dental, and surgical applications. Skincare product categories include mask series, facial cleansing series, and body care series. The biomedical products segment is primarily engaged in the manufacturing and sales of collagen and bone materials, which forms the majority chunk of the revenue of the group. The consumer products segment is engaged in the manufacturing and sales of beauty care products.
Maxigen Biotech (TPE:1783) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TPE:1783 has been successfully added to your